Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt.

Andreas KuznikGarba IliyasuMohammed LamordeMustapha MahmudBaba M MusaIbrahim NashabaruStephen ObaroIdris MohammedAbdulrazaq Garba Habib

Published in: PloS one (2017)

Routine quadrivalent conjugate vaccination against Neisseria meningitidis is cost-effective at incidence rates well below the epidemic threshold among children living in the African meningitis belt.

Keyphrases

clinical practice
cerebrospinal fluid
cancer therapy
young adults
risk factors
early life
drug delivery